Paediatric proteomic signatures of cardiometabolic disease-associated traits predict adult disease outcomes

While the earliest pathological signs of cardiovascular-kidney-metabolic disease (CKMD) emerge before age 20, current adult-based risk thresholds fail to identify a substantial fraction of children at high risk. With increasing childhood obesity, early, sensitive detection of CKMD risk is critical to timely intervention. We linked 25 CKMD phenotypes spanning liver, adipose, vascular and dysglycaemia traits to the circulating proteome in 273 Hispanic or Latino children and adolescents (13.1 ± 2.7 years; 53% female). Here we show that proteome signatures of CKMD in children are strongly associated with clinical CKMD outcomes in adults. In 685 adults from the same community and 28,256 adults from UK Biobank, we observe high concordance between the paediatric and adult CKMD phenotype-proteome relationships, related to pancreatic beta-cell health and insulin sensitivity, liver homeostasis, inflammation and cholesterol metabolism. Many proteins linked to paediatric CKMD were modifiable with glucagon-like peptide-1 receptor agonist therapy in adults and are linked to genetic liability to CKMD. These findings support an early origin of CKMD disease liability embedded in the human proteome in children, underscoring the value of precision prevention to forestall metabolic disease long before its clinical manifestation.

Authors

Institutions

Publication Details

Journal
Nature Metabolism
Published
2026-09-11
DOI
https://doi.org/10.1038/s42255-026-01589-7
Primary Topic
Chronic Kidney Disease and Diabetes
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Paediatric proteomic signatures of cardiometabolic disease-associated traits predict adult disease outcomes

Andrew Perry, Jessica Sprinkles, Ravi V. Shah, Lauren E. Petty et al.
Nature Metabolism
Chronic Kidney Disease and Diabetes
article

Paediatric proteomic signatures of cardiometabolic disease-associated traits predict adult disease outcomes

Andrew Perry, Jessica Sprinkles, Ravi V. Shah, Lauren E. Petty, Jaclyn Tamaroff, Eric Frankel, Eric Farber‐Eger, Penny Gordon‐Larsen, Absalon Gutierrez, Katie A. Meyer, Alexandra B. Palmer, Joshua M. Landman, Jennifer E Below, Quanhu Sheng, Kristin L. Young, Mariaelisa Graff, Joseph B. McCormick, Victoria L. Buchanan, Jane E. Freedman, Kari E. North, Annie Green Howard, Miryoung Lee, Lindsay Fernández‐Rhodes, Shilin Zhao, Hung‐Hsin Chen, Ting‐Chen Wang, Heather M. Highland, Alexander S Petty, Kahraman Tanrıverdi, Eric R. Gamazon, Rashedeh Roshani, Xinruo Zhang, Anna Lorenz, Ash Breidenbach, Benjamin Lippi, Alyssa Scartozzi, Quinn Wells, Matthew Nayor, Mohammad Y. Anwar, Susan P. Fisher-Hoch, Wanying Zhu, Mohanraj Krishnan, Christine A. Ballard
article en

Abstract

While the earliest pathological signs of cardiovascular-kidney-metabolic disease (CKMD) emerge before age 20, current adult-based risk thresholds fail to identify a substantial fraction of children at high risk. With increasing childhood obesity, early, sensitive detection of CKMD risk is critical to timely intervention. We linked 25 CKMD phenotypes spanning liver, adipose, vascular and dysglycaemia traits to the circulating proteome in 273 Hispanic or Latino children and adolescents (13.1 ± 2.7 years; 53% female). Here we show that proteome signatures of CKMD in children are strongly associated with clinical CKMD outcomes in adults. In 685 adults from the same community and 28,256 adults from UK Biobank, we observe high concordance between the paediatric and adult CKMD phenotype-proteome relationships, related to pancreatic beta-cell health and insulin sensitivity, liver homeostasis, inflammation and cholesterol metabolism. Many proteins linked to paediatric CKMD were modifiable with glucagon-like peptide-1 receptor agonist therapy in adults and are linked to genetic liability to CKMD. These findings support an early origin of CKMD disease liability embedded in the human proteome in children, underscoring the value of precision prevention to forestall metabolic disease long before its clinical manifestation.

Nature Metabolism
Boston University (US), University of North Carolina at Chapel Hill (US), Vanderbilt University (US), Institute of Biomedical Sciences, Academia Sinica (TW), Neurobehavioral Systems (US), The University of Texas Health Science Center (US), Vanderbilt University Medical Center (US), The University of Texas Health Science Center at Houston (US)
National Institutes of Health
Good health and well-being
Openalex Percentile: Top 11%
Chronic Kidney Disease and Diabetes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.